Stephane Rinfret

Summary

Country: Canada

Publications

  1. doi request reprint The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care
    Stephane Rinfret
    Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Circ Cardiovasc Qual Outcomes 2:170-7. 2009
  2. doi request reprint Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation
    Stephane Rinfret
    Interventional Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, 2725 Chemin Ste Foy, Quebec City, QC, Canada
    Heart 99:562-9. 2013
  3. doi request reprint Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen
    Stephane Rinfret
    Interventional Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada
    JACC Cardiovasc Interv 3:1011-9. 2010
  4. doi request reprint Retrograde recanalization of chronic total occlusions from the transradial approach; early Canadian experience
    Stephane Rinfret
    Cardiology Department, Quebec Heart and Lung Institute, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec City, Canada
    Catheter Cardiovasc Interv 78:366-74. 2011
  5. doi request reprint Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting
    Rodrigo Bagur
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, Canada
    Catheter Cardiovasc Interv 74:1010-6. 2009
  6. doi request reprint Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic re
    Eric Larose
    Département Multidisciplinaire de Cardiologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec and Faculté de Médicine de l Université Laval, Quebec City, Quebec, Canada
    J Am Coll Cardiol 55:2459-69. 2010
  7. doi request reprint Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy
    Olivier F Bertrand
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, Canada
    Am J Cardiol 104:1235-40. 2009
  8. doi request reprint Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction
    Jonathan Beaudoin
    Quebec Heart and Lung Institute, Quebec City, Canada
    Cardiovasc Revasc Med 11:218-22. 2010
  9. doi request reprint Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial
    Olivier F Bertrand
    Quebec Heart Lung Institute, Quebec, Canada
    Atherosclerosis 211:565-73. 2010
  10. doi request reprint Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-con
    Olivier F Bertrand
    Quebec Heart Lung Institute, Quebec, Quebec, Canada
    Am J Cardiol 105:1520-7. 2010

Collaborators

Detail Information

Publications52

  1. doi request reprint The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care
    Stephane Rinfret
    Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Circ Cardiovasc Qual Outcomes 2:170-7. 2009
    ..Effective programs to address this problem are lacking. We hypothesized that an information technology-supported management program could help improve blood pressure (BP) control...
  2. doi request reprint Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation
    Stephane Rinfret
    Interventional Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, 2725 Chemin Ste Foy, Quebec City, QC, Canada
    Heart 99:562-9. 2013
    ..Many patients delay or interrupt dual antiplatelet therapy (DAT) after drug-eluting stent (DES) implantation, which increases the risk of stent thrombosis and death...
  3. doi request reprint Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen
    Stephane Rinfret
    Interventional Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Faculty of Medicine, Laval University, Quebec City, Quebec, Canada
    JACC Cardiovasc Interv 3:1011-9. 2010
    ..This study sought to estimate the economic impact of same-day home discharge compared with overnight hospitalization after transradial percutaneous coronary intervention (PCI)...
  4. doi request reprint Retrograde recanalization of chronic total occlusions from the transradial approach; early Canadian experience
    Stephane Rinfret
    Cardiology Department, Quebec Heart and Lung Institute, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec City, Canada
    Catheter Cardiovasc Interv 78:366-74. 2011
    ..Retrograde approach for chronic total occlusions (CTO) improves recanalization success rates. Eight French (Fr) catheters and the femoral approach are advocated...
  5. doi request reprint Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting
    Rodrigo Bagur
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, Canada
    Catheter Cardiovasc Interv 74:1010-6. 2009
    ..No data are available on the long term efficacy of abciximab bolus-only with aspirin and clopidogrel pretreatment and systematic coronary stenting. Our objective was to evaluate the 3-year clinical outcomes in the EASY trial...
  6. doi request reprint Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic re
    Eric Larose
    Département Multidisciplinaire de Cardiologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec and Faculté de Médicine de l Université Laval, Quebec City, Quebec, Canada
    J Am Coll Cardiol 55:2459-69. 2010
    ..The aim of this study was to determine whether a very early imaging strategy improves the prediction of late systolic dysfunction and poor outcomes in ST-segment elevation myocardial infarction (STEMI) compared with traditional predictors...
  7. doi request reprint Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy
    Olivier F Bertrand
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, Canada
    Am J Cardiol 104:1235-40. 2009
    ..With a transradial approach and maximal antiplatelet therapy, greater ACT values did not correlate with an increased risk of bleeding...
  8. doi request reprint Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction
    Jonathan Beaudoin
    Quebec Heart and Lung Institute, Quebec City, Canada
    Cardiovasc Revasc Med 11:218-22. 2010
    ..This trial objective was to assess the impact of EAC on angiographic and clinical outcomes in patients with STEMI...
  9. doi request reprint Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial
    Olivier F Bertrand
    Quebec Heart Lung Institute, Quebec, Canada
    Atherosclerosis 211:565-73. 2010
    ..To assess the efficacy and safety of rosiglitazone on saphenous vein graft (SVG) atherosclerosis prevention and on modification of the global cardiometabolic risk profile...
  10. doi request reprint Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-con
    Olivier F Bertrand
    Quebec Heart Lung Institute, Quebec, Quebec, Canada
    Am J Cardiol 105:1520-7. 2010
    ..A higher dose bolus or IC delivery of abciximab bolus was not associated with improved acute or late results compared to the standard IV dosing and administration...
  11. doi request reprint Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection
    Eric Larose
    Cardiac Catheterization Laboratories, Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Laval, Quebec, Canada
    Catheter Cardiovasc Interv 76:461-70. 2010
    ..We hypothesized that myocardial injury would be reduced in late STEMI by proximal embolic protection (PEP)...
  12. doi request reprint The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis
    Salvatore Mottillo
    Jewish General Hospital McGill University, Montreal, Quebec, Canada
    J Am Coll Cardiol 56:1113-32. 2010
    ....
  13. doi request reprint Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention
    Jimmy Machaalany
    Quebec Heart and Lung Institute, Quebec City, Quebec, Canada
    Am J Cardiol 110:1742-8. 2012
    ..In conclusion, as periprocedural PCI bleeding avoidance strategies have become paramount to optimize the clinical benefit, the interaction between bivalirudin and radial approach deserves additional investigation...
  14. pmc The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials
    Mark J Eisenberg
    Division of Cardiology, Jewish General Hospital McGill University, 3755 Cote Ste Catherine Road, Montreal, Quebec, Canada
    Can J Cardiol 26:73-9. 2010
    ..Therefore, a meta-analysis of randomized controlled trials (RCTs) was performed to determine the efficacy of behavioural therapy and pharmacotherapy for smoking cessation in cardiac patients...
  15. doi request reprint Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting
    Olivier F Bertrand
    Quebec Heart Lung Institute, Quebec, Quebec, Canada
    Am J Cardiol 106:155-61. 2010
    ..Measures to prevent anemia and blood loss during PCI remain to be further studied...
  16. doi request reprint Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI
    Josep Rodes-Cabau
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, 2725, Chemin Sainte Foy, Quebec, Canada
    Circulation 120:1978-86. 2009
    ..We determined the effects of sealing moderate nonsignificant SVG lesions with paclitaxel-eluting stents (PES) on the prevention of SVG atherosclerosis progression...
  17. doi request reprint Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements
    Josep Rodes-Cabau
    Interventional Cardiology Laboratories, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
    Am J Cardiol 108:483-90. 2011
    ....
  18. ncbi request reprint A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Clin Ther 29:519-28. 2007
    ..Statins differ in their LDL-C-lowering effects and acquisition costs. Atorvastatin and simvastatin are the 2 most commonly used statins in Canada...
  19. doi request reprint Incidence and clinical impact of concurrent chronic total occlusion according to gender in ST-elevation myocardial infarction
    Yoann Bataille
    Department of Cardiology, Quebec Heart Lung Institute, Quebec City, Canada
    Catheter Cardiovasc Interv 82:19-26. 2013
    ..To determine the prevalence of a concurrent CTO in men and women and to examine its impact on mortality...
  20. doi request reprint Class effects of statins in elderly patients with congestive heart failure: a population-based analysis
    Stephane Rinfret
    Division of Cardiology, Department of Medicine, Centre Hospitalier de l Universite de Montreal, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 155:316-23. 2008
    ..Long-term treatment with statins reduces mortality in patients with congestive heart failure (CHF). Whether statin agents exert a class effect is unknown...
  21. doi request reprint Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial
    Mark J Eisenberg
    Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital McGill University, Montreal, Quebec City, Canada
    J Am Coll Cardiol 61:524-32. 2013
    ..The purpose of this study was to examine smoking cessation rates among smokers with AMI to determine whether bupropion, started in-hospital, is safe and can improve cessation rates at 1 year...
  22. doi request reprint Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome
    Rodrigo Bagur
    Quebec Heart Lung Institute, Quebec, Quebec, Canada
    Am J Cardiol 104:624-9. 2009
    ..However, older patients remain more prone to gastrointestinal bleeding and local hematoma compared to younger patients, and preventive measures need to be further investigated...
  23. doi request reprint Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses
    Javier Courtis
    Interventional Cardiology Laboratories, Quebec Heart Institute Laval Hospital, Quebec, Canada
    Am J Cardiol 103:943-9. 2009
    ..However, patients with diabetes remain at higher risk, and higher doses than previously recommended of intracoronary adenosine might have to be used in the evaluation of LMCA stenosis...
  24. doi request reprint Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction
    Yoann Bataille
    Quebec Heart Lung Institute, Quebec, Canada
    Heart 98:1732-7. 2012
    ..To investigate the predictors and impact on long-term survival of one chronic total occlusion (CTO) or multiple CTOs in patients presenting with ST-elevation myocardial infarction (STEMI)...
  25. doi request reprint Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review
    Samuel Abourbih
    Division of Cardiology, Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
    Am J Med 122:962.e1-8. 2009
    ..New data from fibrate trials can be synthesized with the existing literature to better estimate their effects...
  26. ncbi request reprint A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention
    James M Brophy
    Division of Cardiology, Royal Victoria Hospital McGill University Health Center, Montreal, Quebec, Canada
    Am Heart J 152:263-9. 2006
    ....
  27. doi request reprint Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuation
    Jason R Guertin
    Centre Hospitalier de Université de Montréal Research Centre, Universite de Montreal, Quebec, Canada
    Circ Cardiovasc Qual Outcomes 4:46-52. 2011
    ..Percutaneous coronary intervention (PCI) remains limited by the risk of restenosis. Patients' perceptions of the health benefits and value of avoiding restenosis are incompletely known...
  28. ncbi request reprint The safety and feasibility of immediately returning patients transferred for primary percutaneous coronary intervention with ST-elevation myocardial infarction
    Alexis Matteau
    Division of Cardiology, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    EuroIntervention 5:599-603. 2009
    ..To describe the safety of immediate retransfer to community hospitals following primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI)...
  29. doi request reprint Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis
    Jean Michel Paradis
    Institut Universitaire de Cardiologie et de Pneumologie de Québec Quebec Heart and Lung Institute, Quebec City, Canada
    Circ Cardiovasc Interv 3:565-76. 2010
    ..The objective of this meta-analysis was to assess the cumulative evidence regarding the efficacy and effectiveness of DES to treat SVG compared with bare metal stent (BMS)...
  30. doi request reprint Five-Year Follow-up of the Plaque Sealing With Paclitaxel-Eluting Stents vs Medical Therapy for the Treatment of Intermediate Nonobstructive Saphenous Vein Graft Lesions (VELETI) Trial
    Josep Rodes-Cabau
    Quebec Heart and Lung Institute, Quebec City, Quebec, Canada Electronic address
    Can J Cardiol 30:138-45. 2014
    ....
  31. pmc Effectiveness of a change in reperfusion strategy to primary percutaneous coronary intervention in a nonselected population
    Alexis Matteau
    Division of General Cardiology, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 25:e279-83. 2009
    ..However, the clinical effectiveness of the primary PCI strategy with modern adjunctive antiplatelet therapy deserves further evaluation...
  32. doi request reprint Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention
    Dominique Joyal
    Division of Cardiology, Jewish General Hospital McGill University, Montreal, Quebec, Canada
    Am J Cardiol 109:813-8. 2012
    ..59-2.92). In conclusion, in patients undergoing primary PCI, the radial approach is associated with lower short-term mortality. When feasible, the radial approach should be the favored route in primary PCI...
  33. doi request reprint Analysis of willingness to pay for implantable cardioverter-defibrillator therapy
    Dominika Nowakowska
    Centre Hospitalier de l Université de Montréal Research Centre, Montreal, Quebec, Canada
    Am J Cardiol 107:423-7. 2011
    ..In conclusion, ICD recipients would be willing to pay a substantial amount for a replacement ICD. Considering the expensive price of the device, ICD recipients value favorably the benefits provided by the ICD...
  34. doi request reprint Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis
    Kristian B Filion
    Division of Cardiology and Clinical Epidemiology, Jewish General Hospital McGill University, Montreal, Quebec, Canada
    Am J Cardiol 103:338-44. 2009
    ..The inclusion of these costs renders the widespread use of DES not cost effective in the United States in terms of cost per quality-adjusted life-year gained and cost per revascularization avoided...
  35. doi request reprint Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data?
    Laurie Lambert
    Institut national d excellence en santé et en services sociaux, Montréa1, Quebec, Canada
    Can J Cardiol 28:162-8. 2012
    ..In Canada, medico-administrative hospital data are readily available, continuously updated, and offer comprehensive coverage of the patient population. However, there is concern about the quality of the information...
  36. doi request reprint Effectiveness of myocardial perfusion scintigraphy to predict coronary anatomy in patients with non-ST elevation acute coronary syndrome
    Brian J Potter
    University of Montreal, Montreal, Quebec, Canada
    Am J Cardiol 104:644-7. 2009
    ....
  37. ncbi request reprint Value of immediate postoperative electrocardiogram to update risk stratification after major noncardiac surgery
    Stephane Rinfret
    Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 94:1017-22. 2004
    ..0 to 3.7 in higher risk patients). We conclude that the immediate postoperative electrocardiogram is a valuable tool to adjust risk stratification, even in patients who have lower risks when undergoing noncardiac surgery...
  38. pmc Economic evaluation of increasing population rates of cardiac catheterization
    Fiona M Clement
    Department of Medicine, Faculty of Medicine, University of Calgary, Foothills Medical Centre North Tower, 9th Floor, 1403 29th Street NW, Calgary, AB T2N 2T9, Canada
    BMC Health Serv Res 11:324. 2011
    ..However, such a strategy should only be undertaken if it is cost-effective...
  39. doi request reprint Impact of socioeconomic deprivation and area of residence on access to coronary revascularization and mortality after a first acute myocardial infarction in Québec
    Claudia Blais
    Institut National de Sante Publique du Quebec, Quebec City, Quebec, Canada
    Can J Cardiol 28:169-77. 2012
    ....
  40. pmc Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era
    Frédéric Poulin
    Centre Hospitalier de l Universite de Montreal CHUM, Montreal, Quebec, Canada
    Can J Cardiol 23:1139-45. 2007
    ..Drug-eluting stents (DES) may promote percutaneous coronary intervention (PCI) procedures in patients traditionally referred for coronary artery bypass graft (CABG) surgery and may save money...
  41. doi request reprint Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis
    Dominique Joyal
    Division of Cardiology, Sir Mortimer B Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Am Heart J 160:179-87. 2010
    ..However, the clinical benefits of this practice remain unclear. The aim of the study was to determine the effectiveness of CTO recanalization on clinical outcomes...
  42. pmc A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coron
    Olivier F Bertrand
    Hopital Laval, Quebec Heart Lung Institute, Quebec, Quebec, Canada
    Can J Cardiol 25:509-15. 2009
    ..However, its role in the prevention of atherosclerosis progression is uncertain...
  43. doi request reprint Validation of the j-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort
    Luis Nombela-Franco
    From the Multidisciplinary Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
    Circ Cardiovasc Interv 6:635-43. 2013
    ..Moreover, its predictive value when using a hybrid antegrade or retrograde approach is unknown. We investigated the performance of the J-CTO score for predicting procedure complexity and success in an independent contemporary cohort...
  44. doi request reprint Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes
    Thao Huynh
    Division of Cardiology, McGill Health University Center, Quebec, Canada
    Am Heart J 166:58-63. 2013
    ..The primary objective of this study is to develop a simple risk score that can be used for early-risk stratification of patients with ACS...
  45. doi request reprint The retrograde technique for recanalization of chronic total occlusions: a step-by-step approach
    Dominique Joyal
    Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    JACC Cardiovasc Interv 5:1-11. 2012
    ..Because the technique can vary substantially, we describe the different alternatives to each step and offer what we perceived to be the most efficient techniques...
  46. doi request reprint Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials
    Salvatore Mottillo
    Division of Cardiology and Clinical Epidemiology, Jewish General Hospital McGill University, 3755 Cote Ste Catherine Road, Suite A 118, Montreal, Quebec, Canada
    Eur Heart J 30:718-30. 2009
    ....
  47. ncbi request reprint A population-based analysis of the class effect of beta-blockers after myocardial infarction
    Stephane Rinfret
    Division of Cardiology, Department of Medicine, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Am Heart J 153:224-30. 2007
    ..Long-term treatment with beta-blockers reduces mortality after acute myocardial infarction (AMI). Whether beta-blockers exert a class effect is unknown...
  48. doi request reprint A novel application of contrast echocardiography to exclude active coronary perforation bleeding in patients with pericardial effusion
    Rodrigo Bagur
    Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada
    Catheter Cardiovasc Interv 82:221-9. 2013
    ..Our series demonstrate the clinical utility and effectiveness of echocardiographic contrast imaging to confirm or exclude active bleeding into the pericardial space when not otherwise visible by conventional imaging measures...
  49. ncbi request reprint Cost effectiveness of the sirolimus-eluting stent in high-risk patients in Canada: an analysis from the C-SIRIUS trial
    Stephane Rinfret
    Pharmaco economics and pharmaco epidemiology unit, Centre Hospitalier de l Universite de Montreal CHUM, Montreal, Quebec, Canada
    Am J Cardiovasc Drugs 6:159-68. 2006
    ..The cost effectiveness of drug-eluting stents in Canada is debated and deserves further evaluation in high-risk patients...
  50. ncbi request reprint Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 152:164-9. 2006
    ..There is a concern that poor compliance to cholesterol lowering agents (CLA) may compromise their potential benefits. The objective of this study was to estimate compliance to CLAs, in the context of clinical practice in Quebec...
  51. pmc Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study
    Thao Huynh
    Division of Cardiology, Department of Cardiology, Montreal General Hospital, Montreal, Quebec, Canada
    CMAJ 175:1527-32. 2006
    ..Through the AMI-QUEBEC Study we sought to describe delays to reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) and to identify factors associated with prolonged delays...
  52. ncbi request reprint Absence of association between infectious agents and endothelial function in healthy young men
    Paul Khairy
    Department of Medicine, Montreal Heart Institute, University of Montreal, Quebec, Canada
    Circulation 107:1966-71. 2003
    ..This study assessed whether infection with Chlamydia pneumoniae (CP), cytomegalovirus (CMV), Epstein-Barr virus (EBV), or Helicobacter pylori (HP) is associated with decreased endothelial function...